Research_Immuno in News 2


There was a quality of life improvement for patients with non-small cell lung cancer who were treated with Keytruda compared to those who had standard chemotherapy, according to new data from the trial presented at the IASLC 17th World Conference on Lung Cancer in Vienna, Austria.
Read the article: